RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Paul B. Tchounwou to Arsenicals

This is a "connection" page, showing publications Paul B. Tchounwou has written about Arsenicals.
Connection Strength

3.130
  1. Kumar S, Tchounwou PB. Arsenic trioxide reduces the expression of E2F1, cyclin E, and phosphorylation of PI3K signaling molecules in acute leukemia cells. Environ Toxicol. 2021 Sep; 36(9):1785-1792.
    View in: PubMed
    Score: 0.715
  2. Kumar S, Yedjou CG, Tchounwou PB. Arsenic trioxide induces oxidative stress, DNA damage, and mitochondrial pathway of apoptosis in human leukemia (HL-60) cells. J Exp Clin Cancer Res. 2014 May 16; 33:42.
    View in: PubMed
    Score: 0.439
  3. Walker AM, Stevens JJ, Ndebele K, Tchounwou PB. Arsenic trioxide modulates DNA synthesis and apoptosis in lung carcinoma cells. Int J Environ Res Public Health. 2010 May; 7(5):1996-2007.
    View in: PubMed
    Score: 0.332
  4. Yedjou CG, Tchounwou PB. Modulation of p53, c-fos, RARE, cyclin A, and cyclin D1 expression in human leukemia (HL-60) cells exposed to arsenic trioxide. Mol Cell Biochem. 2009 Nov; 331(1-2):207-14.
    View in: PubMed
    Score: 0.310
  5. Yedjou CG, Tchounwou PB. In-vitro cytotoxic and genotoxic effects of arsenic trioxide on human leukemia (HL-60) cells using the MTT and alkaline single cell gel electrophoresis (Comet) assays. Mol Cell Biochem. 2007 Jul; 301(1-2):123-30.
    View in: PubMed
    Score: 0.264
  6. Yedjou CG, Moore P, Tchounwou PB. Dose- and time-dependent response of human leukemia (HL-60) cells to arsenic trioxide treatment. Int J Environ Res Public Health. 2006 Jun; 3(2):136-40.
    View in: PubMed
    Score: 0.253
  7. Tchounwou PB, Yedjou CG, Dorsey WC. Arsenic trioxide-induced transcriptional activation of stress genes and expression of related proteins in human liver carcinoma cells (HepG2). Cell Mol Biol (Noisy-le-grand). 2003 Nov; 49(7):1071-9.
    View in: PubMed
    Score: 0.211
  8. Tchounwou PB, Wilson BA, Ishaque AB, Schneider J. Atrazine potentiation of arsenic trioxide-induced cytotoxicity and gene expression in human liver carcinoma cells (HepG2). Mol Cell Biochem. 2001 Jun; 222(1-2):49-59.
    View in: PubMed
    Score: 0.179
  9. Yedjou C, Tchounwou P, Jenkins J, McMurray R. Basic mechanisms of arsenic trioxide (ATO)-induced apoptosis in human leukemia (HL-60) cells. J Hematol Oncol. 2010 Aug 26; 3:28.
    View in: PubMed
    Score: 0.085
  10. Stevens JJ, Graham B, Walker AM, Tchounwou PB, Rogers C. The effects of arsenic trioxide on DNA synthesis and genotoxicity in human colon cancer cells. Int J Environ Res Public Health. 2010 05; 7(5):2018-32.
    View in: PubMed
    Score: 0.083
  11. Yedjou CG, Rogers C, Brown E, Tchounwou PB. Differential effect of ascorbic acid and n-acetyl-L-cysteine on arsenic trioxide-mediated oxidative stress in human leukemia (HL-60) cells. J Biochem Mol Toxicol. 2008 Mar-Apr; 22(2):85-92.
    View in: PubMed
    Score: 0.071
  12. Patlolla AK, Tchounwou PB. Cytogenetic evaluation of arsenic trioxide toxicity in Sprague-Dawley rats. Mutat Res. 2005 Nov 10; 587(1-2):126-33.
    View in: PubMed
    Score: 0.060
  13. Patlolla AK, Tchounwou PB. Serum acetyl cholinesterase as a biomarker of arsenic induced neurotoxicity in sprague-dawley rats. Int J Environ Res Public Health. 2005 Apr; 2(1):80-3.
    View in: PubMed
    Score: 0.058
  14. Graham-Evans B, Cohly HH, Yu H, Tchounwou PB. Arsenic-induced genotoxic and cytotoxic effects in human keratinocytes, melanocytes and dendritic cells. Int J Environ Res Public Health. 2004 Sep; 1(2):83-9.
    View in: PubMed
    Score: 0.056
  15. Ishaque AB, Tchounwou PB, Wilson BA, Washington T. Developmental arrest in Japanese medaka (Oryzias latipes) embryos exposed to sublethal concentrations of atrazine and arsenic trioxide. J Environ Biol. 2004 Jan; 25(1):1-6.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support